Specialty code 1835P2201X · Sacramento, CA
NPI
1689198616
Since 2017
Specialty
Specialty code 1835P2201X
Code 1835P2201X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
3737 Po River Way
Sacramento, CA, 95834
Phone (916) 220-7254
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$318K
2,502 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Mihret Argaw prescribed most often to Medicare patients was Atorvastatin Calcium, with 344 prescriptions and refills. In total Mihret Argaw wrote 2,502 Medicare prescriptions that cost $318K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-14.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 344 | 1,146 | 153 | $4,148 |
| Metformin Hcl Generic | 234 | 777 | 102 | $3,031 |
| Metformin Hcl Er Metformin Hcl | 210 | 684 | 109 | $2,138 |
| Glipizide Generic | 187 | 615 | 92 | $2,560 |
| Humulin N Insulin Nph Human Isophane | 147 | 435 | 66 | $29K |
| Losartan Potassium Generic | 112 | 372 | 51 | $1,364 |
| Ozempic Semaglutide | 100 | 101 | 18 | $74K |
| Jardiance Empagliflozin | 85 | 279 | 41 | $45K |
| Lisinopril Generic | 83 | 277 | 40 | $992 |
| Amlodipine Besylate Generic | 82 | 273 | 41 | $984 |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 78 | 254 | 40 | $1,889 |
| Humulin R Insulin Regular, Human | 70 | 209 | 37 | $14K |
| Glipizide Er Glipizide | 68 | 223 | 31 | $1,923 |
| Liraglutide Generic | 67 | 69 | 21 | $41K |
| Insulin Glargine-Yfgn Generic | 65 | 188 | 41 | $7,882 |
Brand drugs: 693 claims; generic drugs: 1,598 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Mihret Argaw were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.